Consequently, voices are calling for re-emphasis on commitment to the decisions of gradual conquest on the one hand, and to activate oversight over the interests included in the reopening in terms of implementing preventive measures, so that the closure effects that led to the reduction of the positive rate of examinations are not in vain, especially since Lebanon has recently entered the vaccination phase. In light of the global policy of “distillation” of vaccines, more attention is required.
It is known that Lebanon will be next Saturday on a date with the arrival of about 41 thousand doses to complete the vaccination process, which is expected to last more than eight months if the vaccination mechanism proceeds according to the plan. However, the Lebanese government’s delay in granting approval to approve the Russian vaccine has put Lebanon in Rank 30 on the waiting list, “but that will not prevent us from getting the vaccine at the end of next March, as the batches are scheduled to arrive in succession,” according to informed sources.
Under the heading “Herd immunity does not prevent the spread of any new mutated: One dose of vaccine is enough?” Ali Oud wrote in “Al-Akhbar”: In principle, most of the vaccines obtained an emergency use permit based on clinical trials in which two doses of the vaccine were used, says researcher in bacteriology at the Lebanese University, Dr. Qassem Hamzah. He added to “Al-Akhbar”: “It is medically recognized that one dose of any vaccine is beneficial … but definitely less than the two doses.” However, “no change in the scheduling of doses locally is not recommended without any scientific document from the producing company.” Hamza pointed out that the voices calling for extending the period between the two doses were caused by poor production around the world and the need to immunize the largest possible number of people. “The goal now is not to eradicate the virus, but to reduce the number of deaths and hospitalizations. This is what some countries believe can be done with a single dose.”
Meanwhile, the European Center for Disease Control and Prevention warned that “mutated versions against which vaccines may be less effective (…) will likely continue to appear.” And drug groups were asked to work on new-generation vaccines that would be adapted to combat new mutated versions. This week, the European Union and the United States announced the establishment of programs aimed at strengthening the “sequencing” processes necessary to monitor the evolution of mutated copies and to monitor new copies as they emerge.
#Lebanon #reservation #list #vaccines #demand #increasing #globally #local #militancy